Effects of Effleurage Abdominal Massage on Pain and Quality of Life in Primary Dysmenorrhea Among Students in Lahore

Sponsor
University of Health Sciences Lahore (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06057649
Collaborator
(none)
52
2
6

Study Details

Study Description

Brief Summary

To find out the answer of the study question that effleurage abdominal massage has any effect on pain and quality of life in primary dysmenorrhea among university students or nota study will be conducted with an objective to evaluate the effects of effleurage abdominal massage on pain and quality of life in primary dysmenorrhea among university students

Condition or Disease Intervention/Treatment Phase
  • Other: Effleurage Abdominal Massage
N/A

Detailed Description

Primary dysmenorrhea, the commonly occurring gynecological issue faced by young girls. It severely affects quality of female life. It leads to fatigue, psychological issues, lack of interest in selfcare and daily activities that results in absenteeism at work and educational institutes. It also badly affects academic performance and extra-curricular activities. Different pharmacological and non-pharmacological interventions are being used for reducing its negative effects, such as effleurage abdominal massage intend to decrease the problems faced by students as a result of this frightening issue. Here the question arises for health professionals that effleurage abdominal massage has any effect on pain and quality of life in primary dysmenorrhea among university students or not? To find out the answer of this question a study will be conducted with an objective to evaluate the effects of effleurage abdominal massage on pain and quality of life in primary dysmenorrhea among university students. This study holds considerable implications in addressing potential adverse effects associated with pharmacological analgesic agents, thereby mitigating pain, lack of interest in work and enhancing functional capacity, hence improving quality of life. Moreover, it is anticipated to contribute to the reduction of healthcare costs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be randomly allocated to control and experimental group. participants in control group will continue with their routine care and experimental group will receive effleurage abdominal massage alongwith routine practicesParticipants will be randomly allocated to control and experimental group. participants in control group will continue with their routine care and experimental group will receive effleurage abdominal massage alongwith routine practices
Masking:
Single (Outcomes Assessor)
Masking Description:
a third person will be involved as second assessor for blinding
Primary Purpose:
Supportive Care
Official Title:
Effects of Effleurage Abdominal Massage on Pain and Quality of Life in Primary Dysmenorrhea Among Female University Students in Lahore
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: control

participants of control group will receive no intervention. they will be instructed to continue with their routine practices

Experimental: experimental

Participants of experimental group will perform effleurage abdominal massage

Other: Effleurage Abdominal Massage
perform the effleurage massage by following these steps: Lie in supine position with knee slightly flexed. Start from the right lower quadrant, using gentle pressure, rub in tiny clockwise circular motions using any non-analgesic cream, towards right rib cage then towards upper left side, moving down the left side to hip bone. Keep up the circular massage while moving inward, toward your belly button for three minutes. After three minutes, use a little more pressure, continuing the circular movements for 10 minutes. Massage for 10 minutes a day for two months during the first 3 days of the menstrual cycle.

Outcome Measures

Primary Outcome Measures

  1. Measurement of Dysmenorrhea Induced Pain intensity [3 months]

    Outcome Measurement Tool: Numeric Pain Rating Scale: Dysmenorrhea induced pain intensity measured by Numerical pain rating scale will be used having numbers from 0 to 10 to indicate the intensity of pain. Here is a breakdown of the numeric rating pain scale 0: No pain. 1-3: Mild pain. 4-6: Moderate pain. 7-9: Severe pain. 10: Excruciating pain.

  2. Measure the level of Quality of Life [3 months]

    Outcome Measurement Tool: Euroqol-5D-5L scale for Quality of Life: The EQ-5D-5L scale will be used to assess students' quality of life across five dimensions and will allow respondents to indicate their level of functioning or health in each dimension with 1 as highest and 5 as lowest for each dimension. Additionally, EQ-5D-5L includes a visual analog scale (VAS) that will allow respondents to rate their overall health on a scale from 0 (worst imaginable health) to 100 (best imaginable health).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 25 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Unmarried female university students from Lahore

  • Aged between 18-25 years

  • Diagnosed patients by gynecologist with primary dysmenorrhea for three previous consecutive cycles.

  • Regular menstrual cycles ranging 21-35 days lasting for 3-7 days.

  • Having pain score of 6 or more than 6 on Numeric Pain Rating Scale

Exclusion Criteria:
  • Presence of any known abdominal or pelvic disease.

  • Obstructive vaginal or uterine congenital anomalies.

  • Presence of known or suspected secondary dysmenorrhea.

  • History of major abdominal or pelvic surgery in the previous three months.

  • History of hormonal therapy in the last six months.

  • History of using analgesics during menstruation.

  • History of having any medical disease i.e. cardiac and renal disease.

  • Participants doing regular exercise.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Health Sciences Lahore

Investigators

  • Study Chair: Aqeela Sarwar, MS Nursing, PG Nursing

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aqeela Sarwar, Principal Investigator, University of Health Sciences Lahore
ClinicalTrials.gov Identifier:
NCT06057649
Other Study ID Numbers:
  • ION UHS
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aqeela Sarwar, Principal Investigator, University of Health Sciences Lahore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023